Qiagen NVQGEN

13F holders, Q2 2025 (June 30)
3holders −8
0new positions
1sold out
$47.98avg. 13F price*

At the end of Q2 2025, 3 institutions reported holding Qiagen NV (QGEN) in their 13F filings, down 8 from Q1 2025. 0 opened new positions and 1 sold out. The largest holders were Geneos Wealth Management Inc. ($30K), Huntington National Bank ($45) and Brooklyn Investment Group ($0).

Company
Qiagen NV
CUSIP
N72482149
Latest filing quarter
Q2 2026

History

Number of 13F holders

0100200300400 Q1 2024: 269Q1 2024Q2 2024: 300Q2 2024Q3 2024: 324Q3 2024Q4 2024: 316Q4 2024Q1 2025: 11Q1 2025Q2 2025: 3Q2 2025Q3 2025: 2Q3 2025Q4 2025: 2Q4 2025Q1 2026: 2Q1 2026Q2 2026: 1Q2 2026

Total Exit/New Position Q1 2025 → Q2 2025

InstitutionsTotal Value
New Positions0$0
Exits1$4.0M

All 13F filers, Q1 2025 → Q2 2025: 100,482 shares sold, net −100,482 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 3 holders

Geneos Wealth Management Inc. 0.00% Reduce -12.7% 621 $30K
Huntington National Bank 0.00% No change 1 $45
Brooklyn Investment Group 0.00% No change 1 $0

"% of holder's portfolio" is QGEN's weight in each manager's 13F, not the share of Qiagen NV the manager owns.